UNITED STATES - SEPTEMBER 26: The Pfizer Inc. headquarters in New York, U.S., on Wednesday, Sept. 26, 2007. Pfizer Inc.'s experimental kidney cancer treatment shrank tumors in a mid-stage clinical trial, giving the world's largest drugmaker a potential back-up for its Sutent cancer medicine. (Photo by Robert Caplin/Bloomberg via Getty Images)